Tumor doubling time and prognostic assessment of patients with primary lung cancer

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer

• Publication date

  1994-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-PPMID 7922975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of solitary pulmonary nodules.

  1991cited by this paper
• Clinical study using previous miniature radiographs of lung cancer cases detected during radiologic screening program.

  1990cited by this paper
• Clinical and radiographic changes in relation to times of screening and survival in lung cancer cases detected by the miyagi screening program using annual chest radiographs.

  1990cited by this paper
• Analysis of the Diagnostic Process and a Retrospective Study of the Miyagi Annual Chest X-ray Lung Cancer Screening Program

  1988cited by this paper
• Lung cancer. Part I: Etiology, pathology, natural history, manifestations, and diagnostic techniques.

  1986cited by this paper
• Tumour growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma.

  1985cited by this paper
• Comparison of actual survivorship after treatment with survivorship predicted by actual tumor‐volume doubling time from tumor diameter at first observation

  1984cited by this paper
• Non-small-cell lung cancer: results of the New York screening program.

  1984cited by this paper
• Staging of bronchogenic carcinoma.

  1982cited by this paper
• 切除肺癌患者におけるtumor doubling timeとPPD反応

  1979cited by this paper
• The natural history of lung cancer: a review based on rates of tumour growth.

  1979cited by this paper
• Pathogenesis and therapy of lung cancer

  1978cited by this paper
• Lung cancer : natural history, prognosis, and therapy

  1976cited by this paper
• Discussion on the Problems of Early Detection of peripheral Lung Cancer from the Standpoint of the Growth Rate and the Size of the Tumor at Detection

  1976cited by this paper
• The prognostic value of measuring the gross linear radial growth of pulmonary metastases and primary pulmonary cancers.

  1976cited by this paper
• Relationship between the growth rate of human metastases, survival and pathological type.

  1974cited by this paper
• Tumor doubling time and survival of men with bronchogenic carcinoma.

  1974cited by this paper
• Growth rate versus prognosis in resected primary bronchogenic carcinomas

  1973cited by this paper
• Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate.

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Relation between the pathological nature and the growth rate of human tumors.

  1971cited by this paper
• Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease.

  1971cited by this paper
• Peripheral measurable bronchogenic carcinoma. Growth rate and period of risk after therapy.

  1971cited by this paper
• A Roentgen Study of the Small Peripheral Lung Cancer

  1971cited by this paper
• Rates of Growth of Pulmonary Metastases and Host Survival

  1964cited by this paper
• The Detection and Growth of Intrathoracic Neoplasms: The Lower Limits of Radiographic Distinction, the Antemortum Size, the Duration, and the Pattern of Growth as Determined by Direct Mensuration of Tumor Diameters from Random Thoracic Roentgenograms

  1963cited by this paper
• A biomathematical approach to clinical tumor growth

  1961cited by this paper
• Observations on growth rates of human tumors.

  1956cited by this paper

• In Vitro α/β Ratio Variations in Cervical Cancer, with Consequent Effects on Equivalent Dose in 2 Gy Fraction in High-Dose-Rate Brachytherapy

  2025cites this paper
• The Effectiveness and Safety of Integrative Traditional Asian Medicine Therapy in Lung Cancer Patients Undergoing Cancer Standard Treatment: A Protocol for Systematic Review and Meta-analysis

  2025cites this paper
• Incidental pulmonary findings on CT in daily practice: the nodule and the interstitial lung abnormalities - what's old, what's new.

  2025cites this paper
• Clinical Significance of Time‐to‐Surgery and COVID‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer

  2025cites this paper
• Relationships between growth rate and Ki-67 and immune indices in ground-glass nodule-featured lung adenocarcinoma

  2025cites this paper
• Lung cancer associated autoantibody responses are detectable years before clinical presentation

  2025cites this paper
• Growth dynamics of lung nodules: implications for classification in lung cancer screening

  2024cites this paper
• Large malignant solitary fibrous tumour of the pleura and tumour doubling time: A case report and literature review

  2024influential citation
• Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival

  2024cites this paper
• Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition

  2023cites this paper
• A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time

  2023cites this paper
• Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition

  2023influential citation
• Observational Study of the Natural Growth History of Peripheral Small-Cell Lung Cancer on CT Imaging

  2023cites this paper
• Tumor volume doubling time as a potential predictor of prognosis in clinical stage I lung squamous cell carcinoma

  2023cites this paper
• Growth assessment of pure ground-glass nodules on CT: comparison of density and size measurement methods

  2023cites this paper
• 基于三维重建技术的肺磨玻璃结节生长规律研究

  2023cites this paper
• Natural progression of persistent pure ground-glass nodules 10 mm or smaller: long-term observation and risk factor assessment

  2023cites this paper
• Management of pulmonary nodules in women with pregnant intention: A review with perspective

  2023cites this paper
• A mathematical model of the disruption of glucose homeostasis in cancer patients

  2023cites this paper
• Quantifying The Medical Impact of A Missed Diagnosis of Non-Small Cell Lung Cancer on Chest Imaging.

  2022cites this paper
• Radiological precursor lesions of lung squamous cell carcinoma: Early progression patterns and divergent volume doubling time between hilar and peripheral zones.

  2022cites this paper
• Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers

  2022cites this paper
• Advanced lung adenocarcinoma detected by choroidal metastasis in a patient with amyopathic dermatomyositis: A case report

  2022cites this paper
• Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

  2021cites this paper
• Relationship between the three-dimensionally measured tumor doubling time of lung cancer and underlying interstitial lung disease: A retrospective case-control study.

  2021cites this paper
• Prognostic impact of maximum standardized uptake value on 18F‐FDG PET/CT imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective study

  2021cites this paper
• Correlation Between the Tumor Doubling Time and Histologic Subtypes in Thymic Epithelial Tumors: Is It Possible to Differentiate Between Thymoma and Thymic Carcinoma?

  2021cites this paper
• EPR effect: Promising approach for tumor targeted drug delivery

  2021cites this paper
• Repeat lung cancer screenings reveal less CXR abnormalities with different variations than first-time screening

  2021cites this paper
• THE INFLUENCE OF VOLUMETRIC TUMOR DOUBLING TIME ON SURVIVAL OF PATIENTS WITH INTRACRANIAL TUMORS

  2021cites this paper
• An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas

  2021cites this paper
• Avascular tumour growth models based on anomalous diffusion

  2020cites this paper
• Nódulo pulmonar solitario: ¿Es la medición del tiempo de duplicación volumétrica realmente útil para diferenciar lesiones benignas de malignas?

  2020cites this paper
• Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis

  2020cites this paper
• Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group

  2020cites this paper
• Prognostic impact of maximum standardized uptake value (SUVmax) of the primary lesion on survival in advanced non-small-cell lung cancer: A retrospective study

  2020cites this paper
• Prognostic significance of spread through air spaces in pulmonary metastases from colorectal cancer.

  2020cites this paper
• QUANTITATIVE NUCLEAR MEDICINE IMAGING USING ADVANCED IMAGE RECONSTRUCTION AND RADIOMICS

  2019cites this paper
• Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients

  2019cites this paper
• Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer

  2019cites this paper
• Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.

  2019cites this paper
• Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.

  2019cites this paper
• Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer

  2019cites this paper
• The tumor doubling time is a useful parameter for predicting the histological type of thymic epithelial tumors

  2019cites this paper
• A single nuclear polymorphism in let‐7g binding site affects the doubling time of thyroid nodule by regulating KRAS‐induced cell proliferation

  2019cites this paper
• Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer.

  2019cites this paper
• Anomalous Advection-Diffusion Models for Avascular Tumour Growth

  2019cites this paper
• Two Cases of Pulmonary Adenocarcinoma in Situ Resected After 9 and 12 Years’ Follow-up

  2018cites this paper
• Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy

  2018cites this paper
• Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer Patients

  2018cites this paper
• NCCN Lung Cancer Screening , Version 3 . 2018 Clinical Practice Guidelines in Oncology

  2018cites this paper
• The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer.

  2018cites this paper
• EBUS: Faster, cheaper and most effective in lung cancer staging

  2018cites this paper
• Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study

  2018cites this paper
• 早期肺癌进展趋势的影响因素和CT研判

  2018cites this paper
• Edinburgh Research Explorer The Lung Image Database Consortium (LIDC)

  2018cites this paper
• Computational modeling reveals dynamics of brain metastasis in non-small cell lung cancer and provides a tool for personalized therapy

  2018cites this paper
• Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Estimability index for volume quantification of homogeneous spherical lesions in computed tomography

  2017cites this paper
• Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage Lung Cancer

  2017cites this paper
• Is post-treatment standardized uptake value a prognostic factor in unresectable non-small cell lung carcinoma?

  2017cites this paper
• Video‐assisted thoracoscopic lobectomy after percutaneous coronary intervention in lung cancer patients with concomitant coronary heart disease

  2017cites this paper
• Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiation.

  2017cites this paper
• Volume doubling time of lung adenocarcinomas considering epidermal growth factor receptor mutation status of exon 19 and 21: three-dimensional volumetric evaluation.

  2017cites this paper
• Que faire devant la découverte d’un nodule pulmonaire solide sur un CT ou un PET-CT

  2017cites this paper
• Total lesion glycolysis by 18F‐FDG PET/CT is independent prognostic factor in patients with advanced non‐small cell lung cancer

  2017cites this paper
• Same-Day Computed Tomographic Chest Imaging for Pulmonary Nodule Targeting with Electromagnetic Navigation Bronchoscopy: Will It Prevent Unnecessary Procedures?

  2017cites this paper
• Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model

  2017cites this paper
• Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma

  2017cites this paper
• Prognostic Modeling and Analysis of Tumor Response to Fractionated Radiotherapy for Patients with Squamous Cell Lung Cancer

  2017cites this paper
• JOURNAL CLUB: Doubling Time of Thymic Epithelial Tumors Correlates With World Health Organization Histopathologic Classification.

  2017cites this paper
• Doubling time of thymic epithelial tumours on CT: correlation with histological subtype

  2017cites this paper
• Patient characteristics associated with adherence of pulmonary nodule guidelines

  2017cites this paper
• Growth rate of chemotherapy-naïve lung metastasis from colorectal cancer could be a predictor of early relapse after lung resection

  2016cites this paper
• Thyroid Nodule Doubling Time is Not a Reliable Indicator of Benign or Malignant Nature

  2016cites this paper
• Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection

  2016cites this paper
• Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base

  2016cites this paper
• In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model

  2016cites this paper
• Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules

  2016cites this paper
• Detection and size measurements of pulmonary nodules in ultra-low-dose CT with iterative reconstruction compared to low dose CT.

  2016cites this paper
• Emulating the volume of pulminary nodules : A Quantitative approach

  2016cites this paper
• Long‐Term Follow‐up of Small Pulmonary Ground‐Glass Nodules Stable for 3 Years: Implications of the Proper Follow‐up Period and Risk Factors for Subsequent Growth

  2016cites this paper
• Quantification of subclonal selection in cancer from bulk sequencing data

  2016cites this paper
• Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute

  2016cites this paper
• 放射線治療におけるPET/CTの意義―早期肺癌に対する体幹部定位放射線治療を中心に―

  2015cites this paper
• Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

  2015cites this paper
• Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease

  2015cites this paper
• Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer.

  2015cites this paper
• Layered superhydrophobic meshes for controlled drug release.

  2015cites this paper
• Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies.

  2015cites this paper
• Pulmonary Nodule Characterization, Including Computer Analysis and Quantitative Features

  2015cites this paper
• Роль времени задержки лучевой терапии в химиолучевом лечении неоперабельного немелкоклеточного рака легкого iii стадии

  2015cites this paper
• Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.

  2015cites this paper
• Modifying the "Modified Schwartz Equation" for Lung Cancer Volume Estimates.

  2015cites this paper
• Surveillance of the Remaining Nodules after Resection of the Dominant Lung Adenocarcinoma is an Appropriate Follow-Up Strategy

  2014cites this paper
• Modeling the Natural History and Detection of Lung Cancer Based on Smoking Behavior

  2014cites this paper
• Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non–Small-Cell Lung Cancer Patients

  2014cites this paper
• A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting

  2014cites this paper
• Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer

  2014cites this paper
• Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations

  2014cites this paper